How Is CJC-1295 (No DAC) Supplied and Stored?

The short version: CJC-1295 (No DAC) storage and supply summary

CJC-1295 (No DAC), chemically identified as Tetrasubstituted GRF 1-29, is delivered in a freeze-dried (lyophilized) state to maintain structural stability during transit and long-term laboratory preservation. In its lyophilized form, the peptide exhibits excellent thermal resistance and can tolerate transient room temperature exposure (up to 25°C) during standard shipping windows without structural breakdown.

For extended laboratory storage prior to reconstitution, unconstituted vials must be stored in a dedicated freezer at -20°C or lower, protected from direct light exposure. Once reconstituted with a suitable solvent such as bacteriostatic water, the resulting liquid solution must be kept under refrigerated conditions at 2°C to 8°C and utilized within 30 days.

Researchers must strictly avoid repeated freeze-thaw cycles after reconstitution, as liquid phase transitions introduce physical shear stress that ruptures peptide bonds and triggers aggregation. Always inspect batch-specific high-performance liquid chromatography (HPLC) and mass spectrometry (MS) documentation to confirm chemical purity and identity prior to initiating in vitro experimentation.

How is CJC-1295 (No DAC) supplied by PX1 Research?

PX1 Research supplies CJC-1295 (No DAC) as a highly purified, cake-like or granular lyophilized matrix inside high-grade Type I borosilicate glass vials. This specific glass formulation minimizes alkali leaching and maintains optimal chemical inertness, ensuring the peptide does not interact with the vessel walls during storage.

Each vial is sealed using a primary pharmaceutical-grade bromobutyl rubber stopper that offers superior impermeability to moisture and atmospheric gases. The assembly is secured with a tamper-evident, flip-off aluminum crimp seal. This airtight seal preserves the internal vacuum environment created during the lyophilization process, preventing ambient humidity from degrading the dry peptide.

When researchers order 5 mg vials of CJC-1295 (No DAC), the packaging is configured to safeguard the fragile cake structure against mechanical shock during transit. Every unit is labeled with clear lot identifiers, peptide mass, and storage temperature requirements to ensure full chain-of-custody tracking across your laboratory operations.

What is the recommended CJC-1295 (no dac) lyophilized storage temperature?

Proper cjc-1295 (no dac) lyophilized storage protocols depend entirely on the intended duration of preservation before liquid reconstitution. Under desiccated, unconstituted conditions, the peptide displays high baseline thermodynamic stability due to the removal of water molecules required for hydrolysis reactions.

For short-term storage (under 30 days), lyophilized CJC-1295 (No DAC) can be kept at standard refrigeration temperatures between 2°C and 8°C. For medium-term storage (1 to 12 months), vials should be placed in a standard laboratory freezer maintained at -20°C. For long-term archival storage exceeding 12 months, storing the powder in a deep freezer at -80°C prevents baseline thermal degradation over several years.

Vials should remain stored in their original light-blocking packaging or inside dark freezer boxes. Exposure to ultraviolet (UV) or ambient laboratory lighting can cause photo-oxidation of susceptible amino acid residues, leading to structural modifications and loss of active concentration.

How should reconstituted CJC-1295 (No DAC) be handled and stored?

Reconstitution introduces aqueous molecules back into the peptide matrix, dramatically altering its degradation kinetics. Once dissolved in a solvent, CJC-1295 (No DAC) becomes far more vulnerable to enzymatic breakdown, hydrolysis, and chemical oxidation.

Reconstituted CJC-1295 (No DAC) must never be stored at room temperature. The liquid solution must be immediately placed in a laboratory refrigerator at 2°C to 8°C. When reconstituted with bacteriostatic water (containing 0.9% benzyl alcohol as a preservative), the solution typically maintains chemical integrity for up to 30 days under continuous refrigeration.

If reconstituted using sterile water without preservatives, the liquid must be used immediately or within 24 hours under refrigerated conditions to prevent bacterial contamination. Review the detailed CJC-1295 (No DAC) research overview to align your handling practices with published laboratory standards.

Why must freeze-thaw cycles be avoided in peptide research?

Repeatedly freezing and thawing reconstituted peptide solutions is one of the primary causes of experimental inconsistency and peptide degradation. As an aqueous peptide solution freezes, ice crystals form and create localized concentrations of solutes, altering the ambient pH and ionic strength of the remaining liquid phase.

This ice-water interface subjects delicate peptide structures to mechanical shear stress, causing denaturation, loss of secondary structure, and physical aggregation into insoluble fibrils. These aggregates render the active peptide non-functional in receptor binding assays and cellular models.

To avoid freeze-thaw degradation when long-term liquid storage is necessary, researchers should practice single-use aliquoting. Immediately after initial reconstitution, divide the solution into sterile micro-centrifuge tubes at single-assay working volumes. Freeze these individual aliquots once at -20°C or -80°C, and thaw a single tube fully prior to conducting an experiment, discarding any unused remainder.

How does CJC-1295 (No DAC) compare to CJC-1295 with DAC in stability and handling?

Understanding the biochemical distinction between CJC-1295 (No DAC) and CJC-1295 with DAC (Drug Affinity Complex) is vital for proper handling and experimental design. CJC-1295 (No DAC) is a 29-amino-acid synthetic peptide that corresponds to modified GRF 1-29. In contrast, CJC-1295 with DAC incorporates a Lysine linker attached to a reactive maleimide group.

In physical storage terms, both variants are supplied as lyophilized powders and follow similar cold-chain storage parameters. However, their physical behavior and stability profiles in biological systems differ significantly due to the DAC moiety's ability to covalently bind to circulating serum albumin.

Researchers evaluating growth hormone secretagogue pathways often compare short-acting analogs against long-acting formulations. You can compare technical specifications directly by visiting the CJC-1295 with DAC product page or exploring synergistic research compounds like Ipamorelin.

Reconstitution protocols and solvent compatibility for in vitro research

Reconstitution must be executed under strict aseptic laboratory conditions using laminar flow hoods or biological safety cabinets to maintain sterility. Before introducing solvents, allow the lyophilized vial to equilibrate to room temperature; introducing cold liquid into a vacuum-sealed cold vial can cause condensation and erratic dissolution.

The ideal solvent for multi-use analytical workflows is 0.9% bacteriostatic water. Gently introduce the diluent down the glass inner wall of the vial using a micro-syringe. Never stream the solvent directly onto the lyophilized cake, as high mechanical impact can disrupt sensitive peptide chains.

Allow the vial to stand for 5 to 10 minutes, gently swirling the vessel in a circular motion until the powder dissolves completely into a clear, colorless liquid. Never shake or vortex the vial, as vigorous agitation introduces air bubbles and surface tension stress that cause surface denaturation. Browse our entire catalog of research peptides for complementary analytical reagents.

What is CJC-1295 (No DAC) studied for in preclinical research?

In cell culture models and animal research systems, CJC-1295 (No DAC) acts as a growth-hormone-releasing hormone (GHRH) analog. It binds specifically to the GHRH receptor on anterior pituitary somatotrophs, activating the adenylate cyclase signal transduction pathway to stimulate endogenous growth hormone (GH) secretion.

Preclinical studies evaluate CJC-1295 (No DAC) as a tool to sustain physiological GH release patterns and downstream insulin-like growth factor 1 (IGF-1) expression. Researchers investigate these pathways in cell culture models focusing on tissue repair research, cellular differentiation, and protein synthesis dynamics.

Because CJC-1295 (No DAC) lacks the DAC lysine complex, its half-life in biological fluids is relatively brief, allowing investigators to measure rapid, physiological pulsatile spikes in GH without long-lasting systemic accumulation. Additional comparative literature is accessible in the PX1 research database and through dedicated Ipamorelin research insights.

How to vet a supplier for CJC-1295 (No DAC) quality and purity

Due to variations in synthesis methodologies, research peptide quality varies widely across the commercial market. Acquiring unverified compounds risks introducing contaminants, unreacted amino acid fragments, or lipopolysaccharide endotoxins into laboratory assays, yielding false or irreproducible data.

When selecting a vendor, avoid suppliers that fail to provide batch-specific Certificate of Analysis (COA) documents or those that rely on static, outdated documentation across multiple lots. A true COA must include high-performance liquid chromatography (HPLC) chromatograms to confirm chemical purity and mass spectrometry (MS) spectral analysis to verify molecular weight.

Red flags include vendors shipping liquid-form peptides at ambient temperatures, non-transparent sourcing, lack of endotoxin testing, and absolute silence regarding stopper material or glass purity standards. Always verify that your supplier adheres to rigorous analytical verification standards prior to issuing a purchase order.

Standard vendor criteria for laboratory peptide acquisition

To ensure experimental reproducibility, research facilities should evaluate vendor capabilities using a standardized audit checklist. PX1 Research adheres strictly to these baseline quality metrics:

1. Purity Verification: Every lot must test at ≥98.0% purity as determined by HPLC. Subpar vendors often sell crude or 90–95% pure preparations filled with synthesis side-products.

2. Molecular Identity: Identity must be verified via High-Resolution Mass Spectrometry (MS) to match the exact theoretical molecular weight of 3367.9 Da for CJC-1295 (No DAC).

3. Endotoxin Control: Total endotoxin levels must measure below strict thresholds (<0.01 EU/mg) using Kinetic Chromogenic LAL Assays to protect cell culture models from inflammatory contamination.

4. Domestic Synthesis & Packaging: Synthesized, processed, and sealed within ISO-certified USA facilities using Type I borosilicate glass and inert bromobutyl stoppers.

5. Rapid Cold-Chain Shipping: Dispatching orders same-day (M–F) with thermal-insulated protective packaging from strategically located hubs in California and Arizona.

Ordering from PX1 Research

When purchasing laboratory supplies from PX1 Research, you receive verified chemical standards packaged for ultimate stability and immediate lab integration. We offer CJC-1295 (No DAC) in standardized 2 mg, 5 mg, and 10 mg lyophilized formats to meet various experimental scale demands.

Orders placed before our daily cutoff times ship same-day (Monday through Friday) from our CA or AZ logistics facilities, utilizing tracked domestic delivery networks to minimize transit durations. Every order arrives with a direct link to the downloadable, lot-matched COA detailing HPLC purity, MS spectrum, and endotoxin verification.

Whether you require individual vials for exploratory screening or large volume supplies through our wholesale peptide program, PX1 Research supports your facility with responsive technical assistance and batch consistency. Select your required format today to buy CJC-1295 (No DAC) 10 mg vials directly from our verified inventory.